PAS-004 has been well-tolerated, with all treatment-related adverse events (TRAEs) being Grade 1 or 2, no observed cardiac or retinal treatment-related events, and low rates of rash and ...

Wearable sensors remain largely underused, despite their utility in improving data collection and regulatory compliance.

In today's ACT Brief, we examine what the FDA's real-time oversight initiative demands of sponsors, why clinical data ...

Two innovative, forward-thinking organizations show how rebuilding patient trust is becoming the real breakthrough driving ...

Samsung and Alcedis will explore how Galaxy Watch biometric data can support clinical trials, digital endpoints, and drug ...

Resalis Therapeutics today announced the dosing of the first participant in a Phase 1b clinical study of its lead candidate, RES-010, a novel antisense oligonucleotide targeting microRNA-22 (miR-22), ...

Patients who enrolled in a clinical trial expecting their health records to stay confidential now face a different reality: a ...

Daniel Ermann, MD, discusses what long-term clinical trial and real-world data have shown about the benefits and durability ...

Managing non-EDC (Electronic Data Capture) data integration in clinical trials is a challenge that holds significant promise. As clinical studies continue to draw on data from wearable devices like ...

Reliable clinical trial data starts in Phase 1. Learn how early quality signals protect safety and guide confident sponsor decisions.

Well before the term “personalized medicine” first appeared, the notion of healthcare tailored to the individual loomed on ...

India, June 24 -- Tech major Samsung Electronics on Wednesday announced a strategic partnership with Alcedis, a digital-first ...